A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC.
暂无分享,去创建一个
D. Yankelevitz | M. Merad | F. Hirsch | M. Beasley | C. Rolfo | T. Marron | S. Hegde | D. Doroshow | Jorge E Gomez | R. Veluswamy | N. Rohs | C. Hennequin | N. LaMarche | B. Maier | N. Hall | Jessica Le Berichel | Bailey G Fitzgerald | Daniel O'Grady | U. Chadda